Tool maker Enerpac's Q1 sales fall

Enerpac Tool

17/12/2025 21:42

Overview

Industrial tools provider's fiscal Q1 sales fell 1% yr/yr

Company repurchased $15 mln in shares during fiscal Q1

Outlook

Enerpac maintains fiscal 2026 net sales guidance at $635 mln to $655 mln

Company expects fiscal 2026 adjusted EBITDA of $158 mln to $168 mln

Enerpac projects fiscal 2026 adjusted EPS between $1.85 and $2.00

Result Drivers

AMERICAS SALES - Enerpac reported solid sales growth in the Americas, contributing positively to overall performance

CORTLAND BIOMEDICAL GROWTH - Cortland Biomedical saw a 27% increase in sales

UK MARKET SOFTNESS - Service revenue in the IT&S segment declined 26% due to softness in the UK market

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
Miss
$144.20 mln
$145.90 mln (2 Analysts)
Q1 Adjusted EPS
Miss
$0.36
$0.37 (2 Analysts)
Q1 EPS
$0.36
Q1 ADJUSTED NET INCOME
Slight Miss*
$19.20 mln
$19.30 mln (1 Analyst)
Q1 Net Income
$19.1 mln
Q1 Net Debt
$49.4 mln


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

Wall Street's median 12-month price target for Enerpac Tool Group Corp is $51.00, about 29.4% above its December 16 closing price of $39.40

The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 22 three months ago

Press Release: ID:nGNX2LnVQm

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)